| Citation: |
WANG Xiaorui, MENG Kaishun, WENG Yang. Correlations of levels of three novel adipocytokines with bone metabolism in patients with hyperthyroidism[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 28-32. DOI: 10.7619/jcmp.20213893
|
To investigate the relationships of levels of serum serine protease inhibitor (Vaspin), ligand of the receptor that belongs to the G protein-coupled receptor family (Apelin), chemokine with bone metabolism in patients with hyperthyroidism.
A total of 100 patients with hyperthyroidism were divided into normal bone mass group (30 cases), osteopenia group (35 cases) and osteoporosis group (35 cases) according to bone mineral density. The baseline data, serum Vaspin, serum Apelin, serum chemerin levels and bone metabolism indexes were compared among the three groups, and the relationships of serum Vaspin, serum Apelin, serum chemerin levels with bone metabolism indexes were analyzed.
There were no significant differences in gender, age and basic diseases among the three groups (P>0.05). The values of 25 hydroxyvitamin D (25-OH VD) and type Ⅰ procollagen N-terminal propeptide (PINP) significantly decreased with the decrease of bone mineral density, while bone derived alkaline phosphatase (BALP), serum osteocalcin (BGP) and β-collagen specific sequence (β-CTX) values significantly increased with the decrease of bone mineral density (P < 0.05). There were no significant differences in the levels of blood calcium (Ca) and blood phosphorus (P) among the three groups (P>0.05). The levels of parathyroid hormone (PTH), serum Vaspin, Apelin and chemerin in the three groups significantly increased with the decrease of bone mineral density (P < 0.05). The expression levels of serum Vaspin, Apelin and chemerin were positively correlated with bone metabolism indexes (P < 0.05).
The changes of serum Vaspin, Apelin and chemerin levels in patients with hyperthyroidism show certain correlations with the decline of bone mineral density. Clinically, bone metabolism in patients with hyperthyroidism can be evaluated by combined detection of serum Vaspin, Apelin and chemerin levels, and then the relative measures can be performed to prevent osteoporosis.
| [1] |
李晓红, 陈卓, 马润玫. 脂肪因子Vaspin、Chemerin在妊娠期糖尿病孕妇的表达[J]. 大理大学学报, 2017, 2(8): 44-48. doi: 10.3969/j.issn.2096-2266.2017.08.011
|
| [2] |
赵蕾, 陈宗涛, 孙丽, 等. 类风湿关节炎患者骨密度与代谢关系的研究进展[J]. 医学综述, 2020, 26(24): 4841-4845. doi: 10.3969/j.issn.1006-2084.2020.24.011
|
| [3] |
廖婧, 冯正平. 骨钙素对糖、脂代谢的影响及分子机制的研究进展[J]. 中国骨质疏松杂志, 2021, 27(3): 426-430. doi: 10.3969/j.issn.1006-7108.2021.03.023
|
| [4] |
王宏伟. Vaspin对高脂饮食诱导的雄性SD大鼠骨损害的保护作用及机制研究[D]. 济南: 山东大学, 2020.
|
| [5] |
王美霞, 郭彩群, 王先桥, 等. 脂肪、免疫及炎症因子对代谢综合征引起骨质疏松的影响[J]. 中国医学创新, 2020, 17(36): 38-42. doi: 10.3969/j.issn.1674-4985.2020.36.010
|
| [6] |
吴继芳, 朱海泉, 宋婕, 等. 2型糖尿病血清Apelin-13的变化水平与骨质疏松症的关系[J]. 中国骨质疏松杂志, 2019, 25(2): 198-201. doi: 10.3969/j.issn.1006-7108.2019.02.013
|
| [7] |
卢秀波, 田文, 姜可伟, 等. 甲状腺功能亢进症外科治疗中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(11): 1229-1233. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK202011001.htm
|
| [8] |
马兴坡, 牛敏, 申金付, 等. 甲亢患者骨代谢指标与甲状腺激素的相关性及对甲亢性疏松的预测价值[J]. 河北医学, 2021, 27(7): 1085-1090. doi: 10.3969/j.issn.1006-6233.2021.07.006
|
| [9] |
朱于青, 孙琳. 促甲状腺激素与骨代谢[J]. 中国医师杂志, 2019, 21(2): 315-318. doi: 10.3760/cma.j.issn.1008-1372.2019.02.049
|
| [10] |
李玉琳, 赵虬. 骨密度和骨代谢指标在强直性脊柱炎合并骨质疏松患者中的水平变化[J]. 重庆医学, 2021, 50(2): 198-201, 206. doi: 10.3969/j.issn.1671-8348.2021.02.004
|
| [11] |
陈丽娟, 赵世平, 代新华, 等. 甲状腺功能亢进症患者骨密度与血清骨代谢指标的相关性分析[J]. 中国基层医药, 2021, 28(4): 495-499. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFC201310024.htm
|
| [12] |
甄东. 促甲状腺素抑制对分化型甲状腺癌术后女性腰椎骨密度的影响[J]. 中国骨质疏松杂志, 2020, 26(2): 264-267. doi: 10.3969/j.issn.1006-7108.2020.02.022
|
| [13] |
张之梁, 任华, 马燕, 等. 老年颈动脉硬化患者血清Vaspin、Apelin、Omentin-1水平与糖脂代谢及骨密度的关系[J]. 疑难病杂志, 2020, 19(11): 1097-1101. doi: 10.3969/j.issn.1671-6450.2020.11.004
|
| [14] |
ROWICKA G, DYLG H, CHECHOWSKA M, et al. Serum Calprotectin and Chemerin Concentrations as Markers of Low-Grade Inflammation in Prepubertal Children with Obesity[J]. Int J Environ Res Public Health, 2020, 17(20): 7575. doi: 10.3390/ijerph17207575
|
| [15] |
PAWEŁ G, RAFAŁ S, MAURYCY J, et al. The Role of the Adipokines in the Most Common Gestational Complications[J]. Int J Mol Sci, 2020, 21(24): 9408. doi: 10.3390/ijms21249408
|
| [16] |
ERIN B. Taylor. The complex role of adipokines in obesity, inflammation, and autoimmunity[J]. Clin Sci (Lond), 2021, 135(6): 731-752. doi: 10.1042/CS20200895
|
| [17] |
白婧, 代嘉, 高倩, 等. 利拉鲁肽治疗2型糖尿病合并骨质疏松患者血清趋化素水平和骨密度变化的研究[J]. 中国糖尿病杂志, 2020, 28(3): 207-210. doi: 10.3969/j.issn.1006-6187.2020.03.011
|
| [18] |
陈庆昭, 林圣纳, 黎艳珊, 等. 曲美他嗪对老年糖尿病合并高血压血浆骨膜蛋白、血清孤独G蛋白耦联受体配体及内皮功能的影响[J]. 中国老年学杂志, 2021, 41(3): 484-487. doi: 10.3969/j.issn.1005-9202.2021.03.010
|
| [19] |
曾昭池, 汤勇, 张先慧, 等. 外源性Apelin-13通过调控VEGF/PI3K/Akt信号通路促进大鼠股骨骨折愈合[J]. 安徽医科大学学报, 2021, 56(1): 48-53. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE202101010.htm
|
| [20] |
方莉. 甲亢合并骨质疏松患者治疗前后生化指标及骨密度变化的观察[J]. 基层医学论坛, 2020, 24(2): 2-4. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLT202002046.htm
|
| 1. |
刘文通. 甲状腺功能5项对鉴别诊断甲状腺功能亢进和甲状腺功能减退中的价值研究. 黑龙江中医药. 2024(01): 359-361 .
| |
| 2. |
蒋瑞妹，王卓群，牛敏，申金付，秦瑶，李娟. 骨吸收标志物β-CTX与Graves病患者并发高钙血症的相关性. 中国医师杂志. 2023(04): 528-531, 536 .
| |
| 3. |
祖力皮亚·努尔买买提，热依汗尼沙·亚克亚，阿不都力木·斯迪克. 普萘洛尔辅助丙硫氧嘧啶治疗老年甲状腺亢进的疗效及对糖脂代谢和ACTH水平的影响. 中外医疗. 2023(23): 92-95 .
| |
| 4. |
乔辉，丁红娜，孙君. 甲状腺功能亢进患者骨密度、骨代谢、脂肪细胞因子的相关性. 河南医学研究. 2023(22): 4091-4095 .
| |
| 5. |
郭小妮，刘师伟，段瑞雪，赵宇翔，吴亚茹. 脂肪因子vaspin与骨质疏松症相关性的研究进展. 生命的化学. 2022(10): 1905-1912 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: